A joint case review is one of the most powerful and most underused tools for building clinical and laboratory collaboration. Done well, it sharpens diagnostic thinking, reduces errors, and creates the kind of professional respect that no memo or training module can generate.
A Practical How To Guide
Every laboratory processes thousands of results each week. Most are routine. Some are unexpected. A small number are pivotal — the result that changed a diagnosis, the discrepancy that prompted a repeat, the critical value that arrived too late. These cases carry educational gold for everyone involved, yet in most settings they are quietly filed away, their lessons unlearned.
A joint lab and clinical case review changes that. It creates a structured space for lab scientists and providers to examine real cases together, not to assign blame, but to build shared understanding. The result is better science, better clinical judgment, fewer errors, and the kind of mutual respect that transforms two departments operating in parallel into one collaborative care team.
This guide covers how to design, run, and sustain a joint case review program that actually delivers on that promise.
“The moment a lab scientist and a provider sit in the same room and ask ‘what were we each thinking at that point?’ that is the moment the collaboration becomes real.”
What a Joint Case Review Is and Is Not
A joint lab and clinical case review is a structured, recurring meeting in which lab professionals and clinical providers examine selected cases together, focusing on the intersection of laboratory data and clinical decision making. It is not a performance review. It is not a complaint forum. It is not a quality assurance audit, though it naturally feeds into quality improvement.
The tone is educational and collaborative, closer to a teaching conference than an incident debrief. Cases are selected because they are instructive, not because they represent failures. The goal is learning, not accountability, and this distinction must be communicated clearly to all participants before the first session.
Outcomes When It Is Done Right
↓ 28% reduction in repeat testing attributed to result misinterpretation in programs running quarterly reviews
↑ 34% improvement in pre analytical specimen quality scores within 6 months of launch
91% of participants in structured lab and clinical reviews report improved understanding of the other profession’s constraints
How to Design the Format
The most effective joint case reviews are short, focused, and regular. A 60-minute monthly or quarterly session consistently outperforms an ambitious quarterly half day that slowly stops happening. Here is a format that works across a wide range of settings and team sizes.
How to Design the Format
The most effective joint case reviews are short, focused, and regular. A 60-minute monthly or quarterly session consistently outperforms an ambitious quarterly half day that slowly stops happening. Here is a format that works across a wide range of settings and team sizes.
Recommended Session Format – 60 Minutes
0–5 min
Welcome and Framing: Facilitator sets the tone: this is a learning session, not a blame session. Briefly state the two cases to be reviewed.
5–25 min
Case 1 Lab Perspective First
Lab presenter walks through what was received, what was observed analytically, what flags or data checks fired, and what decision was made at the bench. Clinical presenter then describes what they saw in the EHR, how they interpreted it and what clinical action followed.
25–45 min
Case 2 Clinical Perspective First
Alternate the opening presenter to model mutual curiosity. Discussion follows the same structure but starts from the clinical decision point and works backward toward the specimen.
45–55 min
Group Discussion and Takeaways
Open floor: what did each side learn? What would either side do differently? Are there processes or communication changes worth testing?
55–60 min
Action Items and Next Session:
Document any agreed changes. Assign ownership. Set the next date before everyone leaves the room.
Roles and Who Should Be in the Room
Role 01
Facilitator: Ideally from neither side, a quality manager, educator, or neutral lab leader. Keeps discussion on track, ensures both perspectives are heard equally, and prevents the session from becoming a grievance forum.
Role 02
Lab Presenter: The bench scientist or section lead most familiar with the case. Rotate this role across staff — it builds presentation confidence and broadens institutional learning.
Role 03
Clinical Presenter: The ordering provider, NP, PA, or clinical pharmacist most familiar with the case. Rotate to build cross specialty understanding over time.
Role 04
Note Taker: Documents key insights, process questions raised, and action items agreed. Distributes a summary within 48 hours to all participants. This record is what turns discussion into institutional memory.
Choosing the Right Cases
Case selection is where many programs stumble. The temptation is to bring the most dramatic cases, the near misses, the serious errors, the complaints. These are not necessarily the best learning cases, and they carry a risk of making participants feel defensive rather than curious.
A better approach is to select cases from four recurring categories: cases where the lab result changed a clinical diagnosis unexpectedly; cases where a pre analytical variable likely affected a result; cases where a critical value notification did not result in a clear clinical action; and cases where a test was ordered but the result was not acted on. These are instructive without being accusatory, and they surface learning that both sides can immediately apply.
Keep a running case log, a shared document or simple spreadsheet where lab and clinical staff can flag interesting cases as they encounter them throughout the month. By review day, you will have more cases than time, and the selection process itself becomes a conversation about what matters most to each side.
Common Pitfalls and How to Avoid Them
- Letting It Become a Complaint Session
Without a strong facilitator, joint reviews can drift into grievances about TAT, specimen handling, or provider behavior. Establish ground rules at the outset: discuss systems and processes, not individuals.
- Only Inviting Senior Staff
The bench scientists and front line clinical staff who interact with specimens and results daily have the most to gain and contribute from these sessions. Rotate participation broadly, not just among directors and managers.
- No Follow Through on Action Items
Nothing kills a collaborative program faster than a pattern of “we agreed to look into that” with no visible outcome. Assign every action item an owner and a due date and open each subsequent session with a brief update on the previous session’s commitments.
- Scheduling It and Then Canceling It
The first time a session is canceled for a competing priority, the implicit message is that collaboration is optional. Protect the meeting time the same way you would protect an accreditation audit or a regulatory visit.
Starting Small and Scaling Intentionally
The most sustainable joint review programs start with a small, willing group, one section of the lab and one clinical service with an existing relationship or shared interest in improvement. Prove the value there, document the outcomes, and let word of mouth drive expansion. A program that starts with enthusiastic participants and grows organically will always outperform one that is mandated from the top down with reluctant attendees.
At Lab2doctors, we champion the Clinical and Laboratory relationship as one of the most consequential and most underdeveloped partnerships in American healthcare. The joint case review is one of the most practical tools we know of for changing that, one conversation at a time.
